DAFNA Capital Management LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1389933
LOS ANGELES, CA
Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,136,597
+$554,206 QoQ
Shares Held
250,772
0.0% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
3.07%
of 13F equity value
Holder Rank
#66
of 313 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. XENE ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,136,597 | 250,772 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,582,391 | 250,772 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,905,425 | 287,939 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,560,750 | 287,939 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,012,490 | 287,939 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,183,943 | 273,739 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,730,568 | 273,739 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,777,104 | 273,739 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,673,083 | 273,739 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,784,463 | 273,739 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,746,598 | 276,739 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,583,178 | 280,538 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,800,713 | 280,538 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,312,932 | 316,092 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,463,507 | 316,092 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,545,550 | 375,223 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,342,911 | 438,623 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,621,582 | 380,163 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,579,317 | 402,667 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,211,854 | 406,535 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,569,681 | 406,535 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,276,976 | 406,535 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,329,708 | 346,535 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,836,142 | 346,535 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,345,548 | 346,535 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,929,706 | 346,535 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||